SEC Form 4 · accession 0001567619-19-004544
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brent J. Boucher
Officer — SVP and GM of Oncology
Period of report
Feb 12, 2019
Accepted (ET)
Feb 14, 2019 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 12, 2019 | F | 490 | $22.90 | D | 13,543 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The exempt disposition of 490 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on February 12, 2018.